Literature DB >> 11490153

Underdiagnosis and undertreatment of asthma: a 9-year study of Italian conscripts.

G Ciprandi1, A Vizzaccaro, I Cirillo, M Tosca, G Passalacqua, G W Canonica.   

Abstract

BACKGROUND: During the last 20 years, the epidemiology of asthma has been investigated in various populations, thus providing interesting data including the accuracy of diagnosis and the adequacy of treatment.
METHODS: We studied for 9 years the epidemiological features of asthma in a homogeneous population of 18-year-old males referred to La Spezia Military Navy Hospital for a call-up visit (conscripts).
RESULTS: During the period of 1990-1998, 91,700 men were screened at their call-up visit; out of them 5,371 (7%) had asthma, but in 7.4% the disease had not been previously diagnosed. During the observation period there was a significant decrease of the level III severity of asthma, but about one quarter of the asthmatic subjects received no treatment at all. On the other hand, a significant increase in the prescription of inhaled steroids was observed.
CONCLUSION: Despite educational efforts, a not negligible underdiagnosis and inadequate treatment of asthma in young adults still persist. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490153     DOI: 10.1159/000053818

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel.

Authors:  Sang Min Lee; Jong Seong Ahn; Chang Suk Noh; Sei Won Lee
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

2.  Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy.

Authors:  Maria Sandra Magnoni; Marco Caminati; Gianenrico Senna; Fabio Arpinelli; Andrea Rizzi; Anna Rita Dama; Michele Schiappoli; Germano Bettoncelli; Gaetano Caramori
Journal:  Clin Mol Allergy       Date:  2015-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.